In this study, in vivo immuno-PET was used to non-invasively assess the kinetics of CD8+ T-cell biodistribution and tumor infiltration following ICOS agonist antibody treatment as monotherapy or in combination with PD-1 blocking antibody in the EMT6 murine syngeneic tumor model. The gene discussed is CD8A; the disease is neoplasm.